Evaluating a new digestive aid for chronic dyspepsia
Official title: Evaluating the Efficacy of "Digestive Aid" in Functional Dyspepsia: A Randomized Double Blind Control Trial
Run by Tehran University of Medical Sciences · NCT06958952 · Data updated 2026-11-12
This study is testing a new digestive aid to see if it can help people with chronic stomach discomfort feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Tehran University of Medical Sciences Academic / other |
| Locations | 1 site (Tehran) |
| Status | Recruiting |
| Started | April 15, 2025 |
| Main results expected | December 30, 2025 |
| Study ends | March 2026 |
| Registry record updated | May 6, 2025 |
| Trial ID | NCT06958952 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with new onset functional dyspepsia.
✕Probably not a fit
Patients with known gastrointestinal diseases or those currently taking medications that affect gastrointestinal function may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the efficacy of a new product called 'Digestive Aid' in patients suffering from functional dyspepsia, a common gastrointestinal disorder characterized by symptoms such as epigastric pain and early satiation. The study is designed as a double-blind, placebo-controlled trial, where participants will be randomly assigned to receive either the Digestive Aid or a placebo for two months. The diagnosis of functional dyspepsia will be made based on the Rome 4 criteria, and the severity of symptoms will be assessed using the Leeds dyspepsia questionnaire. The trial aims to provide insights into the potential benefits of this new treatment approach for dyspeptic patients.
Why it matters
Potential benefit: If successful, this treatment could significantly alleviate symptoms of functional dyspepsia for many patients.
How similar studies have gone: While there have been studies on various treatments for dyspepsia, the specific approach of using this 'Digestive Aid' is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The new onset dyspeptic patients Exclusion Criteria: * Participants with co-morbidities (known GI diseases) * Taking medications, * Those with abnormal gastrointestinal findings in physical examination and para-clinical investigations
Where it's running
-
Sina Hospital
Tehran, Iran Recruiting
Study contacts
- Principal investigator: Raika Jamali, M.D. — Professor
- Study coordinator: Raika Jamali, Professor
- Email: jamalira@tums.ac.ir
- Phone: +98-21-63120000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combining DEBIRI with chemotherapy for colorectal cancer liver metastases
This study is testing if adding a special treatment called DEBIRI to regular chemotherapy can help patients with colorectal cancer that has spread to the liver feel better and possibly have surgery later.
-
Treatment of cervical cancer with hypofractionated chemoradiotherapy
This study is testing a new way of giving radiation and chemotherapy to see if it works just as well as the standard treatment for people with cervical cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.